Mapi Continues Organic Growth and Expansion
Mapi opens an additional office in London, doubling our current UK footprint with the announcement of a state-of-the-art location for our Global Leadership Center. The new facility is located at Imperial College London’s White City Campus, a research and innovation district in White City, west London. Click here to learn more.
With escalating clinical development expenditures, shortened product exclusivity, and product competitiveness, biopharmaceutical companies face increasing market pressures to expeditiously reach peak product sales. Mapi can help conduct your post-approval studies on a global scale. Learn More >>
Mapi’s Patient Centered Sciences is a consolidation of over 4 decades of innovation and expertise into a harmonized team of experts focused on directly engaging with patients across the entire Healthcare landscape and through the entire treatment lifecycle. Learn More >>
Mapi helps you identify, demonstrate, and confirm your product-value proposition from discovery throughout its entire lifecycle, along line extensions, re-evaluation which will enable you to secure return on investment and mitigate at best market risk exposure over time. Learn More >>
With over 20 years of experience in linguistic validation of Patient and Clinician-Reported Outcomes (PROs and ClinROs), Mapi has always been at the forefront of Linguistic Validation. We're a pure Linguistic Validation specialist team with a unique technology and know-how in cross-cultural adaptation. Learn More >>
Mapi's Strategic Regulatory Services group includes senior consultants with more than 30 years of experience working across a broad range of therapeutic areas. We've worked with North American and European companies of all sizes to manage FDA regulatory projects for our customers. Learn More >>
Mapi Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the field of Patient-Centered Outcomes worldwide. Learn More >>